Inventor · disambiguated record
Masakazu Kobayashi
Also filed as: KOBAYASHI MASAKAZU
21 granted patents·5 pending applications·351 citations·filing 1973–2022
95Inventor score
Files withFUJISAWA PHARMACEUTICAL CO21RII KO2ASTELLAS PHARMA INC1SAKURAI KAZUO1UNIV HOKKAIDO NAT UNIV CORP1
Top patents by PatentIndex Score
26 records- 0195US4298529AAlkoxyimino dioxy butyric acid derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1979·Granted Nov 3, 1981·26 cites·7 claims
- 0290US6069156AIndole derivatives as cGMP-PDE inhibitorsFUJISAWA PHARMACEUTICAL CO·Filed 1996·Granted May 30, 2000·130 cites·9 claims
- 0383US7037892B2Hematopoietic stem cell proliferating agentsASTELLAS PHARMA INC·Filed 2002·Granted May 2, 2006·12 cites·7 claims
- 0483US4703046ACephem compounds and processes for preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1979·Granted Oct 27, 1987·17 cites·12 claims
- 0582US4354022AProcess for preparing 3-methylenecepham compounds or a salt thereofFUJISAWA PHARMACEUTICAL CO·Filed 1981·Granted Oct 12, 1982·13 cites·8 claims
- 0681US4327093A3,7-Disubstituted-2 or 3-cephem-4-carboxylic acid compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1979·Granted Apr 27, 1982·15 cites·9 claims
- 0771US6495365B1Hematopoietic stem cell proliferating agentsFUJISAWA PHARMACEUTICAL CO·Filed 1997·Granted Dec 17, 2002·28 cites·16 claims
- 0870US4001280AChromone derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1973·Granted Jan 4, 1977·7 cites·4 claims
- 0967US5532137AAnti-FR-900506 substance antibodies and highly-sensitive enzyme immunoassay methodFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Jul 2, 1996·38 cites·13 claims
- 1064US9713636B2Nucleic acid/polysaccharide complexRII KO·Filed 2012·Granted Jul 25, 2017·1 cites·4 claims
- 1164US6338946B1Method for assaying immunosuppressantFUJISAWA PHARMACEUTICAL CO·Filed 1999·Granted Jan 15, 2002·25 cites·3 claims
- 1259US2025084127A1Efficient chemo-enzymatic synthesis method for cyclic peptideUNIV HOKKAIDO NAT UNIV CORP·Filed 2022·Application pending·0 cites
- 1358US5648250ATissue plasminogen activatorFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Jul 15, 1997·13 cites·17 claims
- 1458US2003113912A1Hematopoietic stem cell proliferating agentsFUJISAWA PHARMACEUTICAL CO·Filed 2002·Application pending·0 cites
- 1557US2005025769A1Method of suppressing ongoing acute allograft rejectionFUJISAWA PHARMACEUTICAL CO·Filed 2004·Application pending·0 cites
- 1653US2004087480A1Calcium channel target for controlling epidermal keratinocyte growth in psoriasis, and basal and squamous cell carcinomasFUJISAWA PHARMACEUTICAL CO·Filed 2003·Application pending·0 cites
- 1752US5840533ATissue plasminogen activatorFUJISAWA PHARMACEUTICAL CO·Filed 1997·Granted Nov 24, 1998·9 cites·4 claims
- 1850US4594446A2-alkoxyimino-3,3-dialkoxy-butyrates and derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1985·Granted Jun 10, 1986·2 cites·4 claims
- 1949US9801929B2Immune tolerance inducerRII KO·Filed 2012·Granted Oct 31, 2017·0 cites·5 claims
- 2045US5576183AMonoclonal antibody recognizing FK506-binding protein, method for assaying FK506-binding protein level, and kit thereforFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted Nov 19, 1996·8 cites·3 claims
- 2144US4729991ACephem compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Mar 8, 1988·1 cites·12 claims
- 2243US2013142832A1Nucleic acid/ polysaccharide complexSAKURAI KAZUO·Filed 2011·Application pending·0 cites
- 2341US5102985AProcess for the formation of intramolecular disulfide bridge in a polypeptideFUJISAWA PHARMACEUTICAL CO·Filed 1989·Granted Apr 7, 1992·4 cites·5 claims
- 2441US4379922ACepham compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1980·Granted Apr 12, 1983·1 cites·4 claims
- 2539US4399278A3,7-Disubstituted-2 or 3-cephem-4-carboxylic acid compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Aug 16, 1983·1 cites·5 claims
- 2637US4518774A3-Cephem intermediatesFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted May 21, 1985·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Masakazu Kobayashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →